ELDRED KARY bought GALT

February 6, 2026 · Form 4 insider transaction

ELDRED KARY bought 300 shares of Galectin Therapeutics Inc. at $2.70 per share, a transaction worth $810.00. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 3 days after the transaction.